784156-13-4

Basic information

• Product Name: benzyl N,N-bis(tert-butoxycarbonyl)-5-(2,3-dichlorophenyl)-6-nitro-D-norleucinate
• Synonyms: benzyl N,N-bis(tert-butoxycarbonyl)-5-(2,3-dichlorophenyl)-6-nitro-D-norleucinate
• CAS NO: 784156-13-4
• Molecular Weight: 611.519
• Mol File: 784156-13-4.mol

Chemical Properties

• CAS DataBase Reference: benzyl N,N-bis(tert-butoxycarbonyl)-5-(2,3-dichlorophenyl)-6-nitro-D-norleucinate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl N,N-bis(tert-butoxycarbonyl)-5-(2,3-dichlorophenyl)-6-nitro-D-norleucinate(784156-13-4)
• EPA Substance Registry System: benzyl N,N-bis(tert-butoxycarbonyl)-5-(2,3-dichlorophenyl)-6-nitro-D-norleucinate(784156-13-4)

Safety Data

• Hazardous Substances Data: 784156-13-4(Hazardous Substances Data)

Upstream product

• 784156-33-8 benzyl (2R,5E)-2-[bis(tert-butoxycarbonyl)amino]-6-nitrohex-5-enoate 

Downstream Products

• 784156-15-6 benzyl N₂,N₂-bis(tert-butoxycarbonyl)-5-(2,3-dichlorophenyl)-D-lysinate 

Relevant articles and documents

CGRP RECEPTOR ANTAGONISTS

The present invention is directed to compounds of Formula (I) and Formula (II) (where variables R1, R2, R3, R4, A, B, G, J, Q, T, U, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.